Loading provider…
Loading provider…
Surgical Oncology Physician in San Diego, CA
NPI: 1346218179Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get MD Andrew's Phone NumberMobile
Get MD Andrew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
CA State Medical License
2007 - 2026
OH State Medical License
1996 - 2008
TX State Medical License
1993 - 1997
NY State Medical License
1989 - 1994

American Board of Surgery
Surgery
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1988
New York Presbyterian Hospital (Cornell Campus)
Residency • Surgery
1988 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 48 | 56 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 39 | 45 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 35 | 35 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 14 | 14 |
| 5 | 48150Partial removal of pancreas, bile duct and small bowel with connection of pancreas to small bowel | 12 | 12 |
PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes
Authors: Brian Datnow, Sarah Blair, Huan-You Wang, Scott Vandenberg
Publication Date: 2013-05
Surgery as adjuvant therapy? The treatment of peritoneal metastases from gastrointestinal malignancy.
Authors: Andrew M. Lowy
Publication Date: 2001-12
Authors: Syed Ahmad, Amod Sarnaik
Journal: Recent Results Cancer Res
Lead Sponsor: Brown University
Collaborators: Sanofi, University of California, San Diego, Montefiore Medical Center, University of Florida, Rhode Island Hospital, The Miriam Hospital, Lifespan
Intervention / Treatment: DRUG: Aflibercept
Lead Sponsor: Orano Med LLC
Intervention / Treatment: BIOLOGICAL: trastuzumab, OTHER: ²¹²Pb-TCMC-Trastuzumab